SMC approves Xermelo for carcinoid syndrome diarrhoea
Scotland is the first country in the UK to enable patients, battling this serious and debilitating condition, access to a new treatment option...
List view / Grid view
Scotland is the first country in the UK to enable patients, battling this serious and debilitating condition, access to a new treatment option...
Findings may represent simple and potentially low-cost intervention...
Results from a pivotal trial of a new HIV therapy, show that PRO 140 is an effective, long-acting therapeutic for previously treated HIV-1 infected patients...
OPTEL GROUP, a leading global provider of traceability systems for diverse industries, namely for pharmaceuticals, medical devices, healthcare, food and natural resources, announced today that it will be exhibiting an entirely serialised line at this year’s edition of Achema, from 11 - 15 June 2018, in Frankfurt, Germany, at Stand F31…
Acidosis related to use of metformin seen only in those with severely decreased kidney function...
Once-daily oral pill could replace preoperative chemotherapy in patient population if validated in larger trials...
Scientists have developed a new way of seeing when heavy wound scars are forming and providing doctors with the chance to intervene...
Researchers hope immunotherapy will prevent against overactive immune response...
Two new studies of patients with difficult-to-control asthma show that the eczema drug dupilumab alleviates asthma symptoms and improves patients' ability to breathe better than standard therapies...
Replacement neurons, blood vessels fill in stroke cavity; gel provides scaffolding...
Nanoparticles could offer a new way to help eradicate the disease worldwide...
The FDA has approved Retacrit as a biosimilar to Epogen/Procrit for the treatment of anaemia caused by chronic kidney disease, chemotherapy, or use of zidovudine in patients with HIV infection...
New catalyst is specifically tuned to integrate fluorine atoms into a new organic product...
The FDA has approved Gilenya to treat relapsing multiple sclerosis in children and adolescents age 10 years and older...
The approval provides paediatric epilepsy patients a treatment option which can be initiated at a therapeutic dose from day one...